Avantax Planning Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-34	Closed	-$6K	–	801
2018 Q3	$6K	Buy	+34	New	+$6K	﹤0.01%	1033
2018 Q2	–	Sell	-53	Closed	-$4K	–	911
2018 Q1	$4K	Buy	+53	New	+$4K	﹤0.01%	1426